Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea · Delayed Price · Currency is KRW 4,080.00
-75.00 (-1.81%)
At close: Oct 23, 2026
Sinsin Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 123,051 | 113,778 | 106,388 | 102,586 | 91,926 | 74,008 |
Revenue Growth | 14.86% | 6.95% | 3.71% | 11.60% | 24.21% | 10.25% |
Gross Profit Gross Profit Growth | 48,049 | 43,009 | 36,110 | 33,312 | 30,220 | 21,689 |
Operating Income Operating Income Growth | 14,538 | 10,790 | 6,890 | 6,004 | 5,426 | -1,343 |
Net Income Net Income Growth | 13,466 | 9,292 | 4,888 | 4,680 | 4,415 | -1,476 |
Earnings Per Share EPS Growth | 887.51 | 612.51 | 322.24 | 308.49 | 291.00 | -97.29 |
EPS Growth | 224.10% | 90.08% | 4.46% | 6.01% | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 98,237 | 92,481 | 88,256 | 79,331 | 63,998 |
Export Export Growth | 15,541 | 13,907 | 14,330 | 12,595 | 10,010 |
Total Total Growth | 113,778 | 106,388 | 102,586 | 91,926 | 74,008 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,983 | 3,876 | 539.85 | 346.46 | 2,240 | 799.33 |
Total Debt Total Debt Growth | 40,076 | 43,695 | 45,606 | 44,505 | 43,481 | 46,236 |
Net Cash (Debt) Net Cash Growth | -37,093 | -39,818 | -45,066 | -44,158 | -41,241 | -45,437 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2445.08 | -2624.72 | -2970.66 | -2910.81 | -2718.51 | -2995.06 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13,979 | 8,584 | 5,943 | 3,930 | 5,461 | 23.18 |
Capital Expenditures CapEx Growth | -2,226 | -1,612 | -1,505 | -5,011 | -907.13 | -2,682 |
Free Cash Flow Free Cash Flow Growth | 11,754 | 6,971 | 4,439 | -1,081 | 4,553 | -2,659 |
Free Cash Flow Growth | 395.80% | 57.05% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.05% | 37.80% | 33.94% | 32.47% | 32.87% | 29.31% |
Operating Margin | 11.82% | 9.48% | 6.48% | 5.85% | 5.90% | -1.81% |
Pretax Margin | 11.94% | 8.62% | 4.83% | 3.89% | 4.40% | -2.36% |
Profit Margin | 10.94% | 8.17% | 4.59% | 4.56% | 4.80% | -1.99% |
FCF Margin | 9.55% | 6.13% | 4.17% | -1.05% | 4.95% | -3.59% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 80.000 | - | - | - | - | - |
Dividend Per Share Growth | 33.33% | - | - | - | - | - |
Dividend Yield | 1.96% | - | - | - | - | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.60 | 9.57 | 16.85 | 20.23 | 19.18 | - |
P/FCF Ratio | 5.27 | 12.75 | 18.56 | - | 18.59 | - |
PS Ratio | 0.50 | 0.78 | 0.77 | 0.92 | 0.92 | 1.32 |